Bttx stock forecast.
STRR Sales Forecast. Next quarter’s sales forecast for STRR is $9.15M with a range of $9.00M to $9.30M. The previous quarter’s sales results were $10.44M. STRR beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 46.24% of the time in the same period.
Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Evofem Biosciences Inc have a median target of 225.00, with a high estimate of 225.00 and a low estimate of 225.00. The ...View Better Therapeutics Inc (BTTX) stock price today, market news, streaming charts, forecasts and financial information from FX Empire.Stock Price Forecast The 2 analysts offering 12-month price forecasts for Better Therapeutics Inc have a median target of 5.25, with a high estimate of 9.00 and a low estimate of 1.50.Their BTTX share price targets range from $3.00 to $9.00. On average, they anticipate the company's share price to reach $6.00 in the next year. This suggests a possible upside of 3,131.0% from the stock's current price. View analysts price targets …WebGet the latest BTTX stock quote, history, news and other vital information to help you with your stock trading and investing. See the current price, performance outlook, earnings …Web
Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas...Get the latest Better Therapeutics Inc (BTTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Current. -$0.19. 1 Month Ago. -$0.26. 3 Months Ago. -$0.31. Better Therapeutics Inc. analyst estimates, including BTTX earnings per share estimates and analyst recommendations.WebWhat this means: InvestorsObserver gives Better Therapeutics Inc (BTTX) an overall rank of 34, which is below average. Better Therapeutics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of stocks appear more favorable to our system.
The consensus price target of analysts on Wall Street is $6.00, which implies an increase of 97.33% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $3.00 and $9.00 respectively. As a result, BTTX is trading at a discount of -5525.0% off the target high and -1775.0% off the low.View research reports from Argus and trade ideas from Trading Central to understand future stock performances and find high performing trade ideas.NASDAQ Health Care/Life Sciences Compare to Open 0.20 Prior Close 0.19 (11/29/23) 1 Day BTTX -8.21% DJIA 0.04% Russell 2K 0.61% Health Care/Life Sciences 0.40% Overview Per-Share Earnings,...Wall Street Stock Market & Finance report, prediction for the future: You'll find the BioXcel Therapeutics share forecasts, stock quote and buy / sell signals below. According to present data BioXcel Therapeutics's BTAI shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Based on short-term price targets offered by two analysts, the average price target for Better Therapeutics, Inc. comes to $6.00. The forecasts range from a low of $3.00 to a high of $9.00. The ...
Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Evofem Biosciences Inc have a median target of 225.00, with a high estimate of 225.00 and a low estimate of 225.00. The ...
Latest SEC filings for Better Therapeutics, Inc. (BTTX).
Find the latest BriaCell Therapeutics Corp. (BCTX) stock quote, history, news and other vital information to help you with your stock trading and investing.The Better Therapeutics, Inc. stock forecast for tomorrow is $ 0.223794, which would represent a 15.18% gain compared to the current price. In the next week, the price of BTTX is expected to increase by 24.54% and hit $ 0.241978. As far as the long-term Better Therapeutics, Inc. stock forecast ... TipRanks is a platform that provides comprehensive data and analysis on stocks, including Better Therapeutics, Inc. (BTTX), a digital therapeutics company. Find out the latest price targets, ratings, news, and earnings for BTTX on TipRanks.GRAB Stock 12 Months Forecast. Based on 9 Wall Street analysts offering 12 month price targets for Grab in the last 3 months. The average price target is $4.41 with a high forecast of $5.40 and a low forecast of $3.15. The average price target represents a 41.12% change from the last price of $3.13.Find the latest Sidus Space, Inc. (SIDU) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...
Great weather can motivate you to get out of the house, while inclement weather can make you feel lethargic. When the weather’s great we want to be outside enjoying it. For the best regional weather forecasts check out AccuWeather.About Better Therapeutics, Inc. 548 MARKET STREET,SUITE 49404 SUITE 49404, SAN FRANCISCO, California, 94104, United States +1 415 887-2311 https://www.bettertx.com. Better Therapeutics Inc is a ...The 12-month stock price forecast is $3.15, which is an increase of 1,189.93% from the latest price. Price Target. $3.15 (1,189.93% upside) Analyst Consensus: Strong Buy. Stock Forecasts. ... BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT) The most oversold stocks in the health care sector presents an opportunity to buy into …GEVO Stock 12 Months Forecast. $6.47. (528.16% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Gevo in the last 3 months. The average price target is $6.47 with a high forecast of $14.00 and a low forecast of $2.00. The average price target represents a 528.16% change from the last price of $1.03.The 12-month stock price forecast is $3.15, which is an increase of 1,189.93% from the latest price. Price Target. $3.15 (1,189.93% upside) Analyst Consensus: Strong Buy. Stock Forecasts. ... BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT) The most oversold stocks in the health care sector presents an opportunity to buy into …
As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.
12 analysts have issued 1-year target prices for Six Flags Entertainment's shares. Their SIX share price targets range from $16.00 to $35.00. On average, they anticipate the company's share price to reach $27.38 in the next year. This suggests a possible upside of 10.8% from the stock's current price.Get free stock tools, free stock ratings, free stock charts and calculate the value of stocks to buyFind the latest Lixte Biotechnology Holdings, Inc. (LIXT) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short ...Find the latest Lithium Americas Corp. (LAC) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Stock Price Forecast. The 1 analysts offering 12-month price forecasts for UpHealth Inc have a median target of 3.50, with a high estimate of 3.50 and a low estimate of 3.50.July 27, 2023 at 11:42 AM · 3 min read. The recent price decline of 15% in Better Therapeutics, Inc.'s ( NASDAQ:BTTX) stock may have disappointed insiders who bought US$5.1m worth of shares at an ...
The Company has filed a form S-1 registration statement on 11/26/2021 with the SEC for the sale of up to 20,406,908 shares of common stock, by certain listed selling stockholders including PIPE ...
Better Therapeutics Inc (NASDAQ:BTTX) trade information. Instantly BTTX has been showing red trend so far today with a performance of -9.01% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.2280 on Monday, 11/27/23 increased the stock’s daily price by 21.05%.
Track Better Therapeutics Inc (BTTX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable …WebMar 20, 2021 · In my view, the absolute worst pot stock that money can buy is penny stock Sundial Growers ( SNDL -4.67%). Shares of Sundial, a Canadian licensed producer, are up about 1,000% since late October ... Their BTTX share price targets range from $3.00 to $9.00. On average, they anticipate the company's share price to reach $6.00 in the next year. This suggests a possible upside of 3,131.0% from the stock's current price. View analysts price targets for BTTX or view top-rated stocks among Wall Street analysts.View research reports from Argus and trade ideas from Trading Central to understand future stock performances and find high performing trade ideas. The P/E ratio on projected 2023 earnings is 23, above the market multiple. Earnings are expected to grow 14.5% in 2023 after having fallen 3.3% in 2022. Earnings rose 37.9% in 2021 and 7.7% in ...5.25 0.00 0.00% The 2 analysts offering 1 year price forecasts for BTTX have a max estimate of — and a min estimate of —. Analyst rating Based on 2 analysts giving stock …WebStock Price Forecast. The 13 analysts offering 12-month price forecasts for Northern Oil and Gas Inc have a median target of 51.00, with a high estimate of 60.00 and a low estimate of 44.00. The ...The AcelRx Pharmaceuticals stock price gained 3.66% on the last trading day (Wednesday, 15th Nov 2023), rising from $0.464 to $0.481. During the last trading day the stock fluctuated 11.04% from a day low at $0.450 to a day high of $0.500. The price has fallen in 6 of the last 10 days and is down by -9.09% for this period.Nokia has 5,691,797,400 shares outstanding. What happened to Nokia’s price movement after its last earnings report? Nokia reported an EPS of $0.053 in its last earnings report, missing expectations of $0.079. Following the earnings report the stock price went down -5.06%.Find the latest BiomX Inc. (PHGE) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid Term ...We would like to show you a description here but the site won’t allow us.Stock Price Forecast. The 3 analysts offering 12-month price forecasts for UpHealth Inc have a median target of 7.00, with a high estimate of 9.75 and a low estimate of 4.30. The median estimate ...
Find the latest Inspirato Incorporated (ISPO) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...3 Nov 2023 ... BTTX Price Action: Shares of Better Therapeutics fell 6.1% to close at $0.15 on Thursday. Heart Test Laboratories Inc HSCS. On Sept. 18, Heart ...TipRanks | Stock Market Research, News and Analyst Forecasts ...Instagram:https://instagram. most profitable crypto trading strategyc3 ai competitorsai agewho offers bank statement loans Average target price for BTTX - Better Therapeutics is predicted at $3.689 within next 1 year best penny stocks appnasdaq fcnca The average price target for Ginkgo Bioworks Holdings is $3.50. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $7.00 ,the lowest forecast is $1.50. The average price target represents 144.76% Increase from the current price of $1.43. dividend rate apy Get the latest Better Therapeutics Inc (BTTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Stock Price Forecast According to 1 stock analyst, the 12-month stock price forecast for ACXP stock stock is $13, which predicts an increase of 243.01%. On average, analysts rate ACXP stock stock as a strong buy.Track Better Therapeutics Inc (BTTX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors